Pacific Biosciences (PACB)
NASDAQ:PACB
Holding PACB?
Track your performance easily

Pacific Biosciences (PACB) Financial Statements

2,413 Followers

Pacific Biosciences Financial Overview

Pacific Biosciences's market cap is currently ―. The company's EPS TTM is $-1.455; its P/E ratio is -1.69; Pacific Biosciences is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 36.01M$ 38.81M$ 58.36M$ 55.69M$ 47.57M
Gross Profit$ 5.94M$ 11.28M$ 9.57M$ 17.90M$ 15.55M
EBIT$ -173.32M$ -69.10M-$ -73.99M$ -69.83M
EBITDA$ -159.03M$ -57.08M-$ -68.53M$ -64.97M
Net Income Common Stockholders$ -173.32M$ -78.18M$ -82.02M$ -66.87M$ -69.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 509.80M$ 561.91M$ 631.42M$ 767.79M$ 829.86M
Total Assets$ 1.51B$ 1.67B$ 1.75B$ 1.90B$ 1.85B
Total Debt$ 924.95M$ 931.37M$ 933.44M$ 935.56M$ 937.64M
Net Debt$ 415.15M$ 369.45M$ 302.02M$ 167.77M$ 107.78M
Total Liabilities$ 1.02B$ 1.02B$ 1.04B$ 1.13B$ 1.21B
Stockholders Equity$ 492.70M$ 649.02M$ 701.30M$ 763.74M$ 642.00M
Cash Flow-
Free Cash Flow$ -55.74M$ -79.56M-$ -66.01M$ -44.01M
Operating Cash Flow$ -54.26M$ -75.68M$ -57.56M$ -65.18M$ -41.74M
Investing Cash Flow$ 76.84M$ -34.14M$ -66.58M$ 242.32M$ -98.59M
Financing Cash Flow$ -152.00K$ 6.55M$ -81.60M$ -781.00K$ -4.71M
Currency in USD

Pacific Biosciences Earnings and Revenue History

Pacific Biosciences Debt to Assets

Pacific Biosciences Cash Flow

Pacific Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis